Recent advances in the development of chitosan/hyaluronic acid-based hybrid materials for skin protection, regeneration, and healing: A review.

Biomaterials play vital roles in regenerative medicine, specifically in tissue engineering applications. They promote angiogenesis and facilitate tissue creation and repair. The most difficult aspect of this field is acquiring smart biomaterials that possess qualities and functions that either surpass or are on par with those of synthetic products. The biocompatibility, biodegradability, film-forming capacity, and hydrophilic nature of the non-sulfated glycosaminoglycans (GAGs) (hyaluronic acid (HA) and chitosan (CS)) have attracted significant attention. In addition, CS and HA possess remarkable inherent biological capabilities, such as antimicrobial, antioxidant, and anti-inflammatory properties. This review provides a comprehensive overview of the recent progress made in designing and fabricating CS/HA-based hybrid materials for dermatology applications. Various formulations utilizing CS/HA have been developed, including hydrogels, microspheres, films, foams, membranes, and nanoparticles, based on the fabrication protocol (physical or chemical). Each formulation aims to enhance the materials' remarkable biological properties while also addressing their limited stability in water and mechanical strength. Additionally, this review gave a thorough outline of future suggestions for enhancing the mechanical strength of CS/HA wound dressings, along with methods to include biomolecules to make them more useful in skin biomedicine applications.
Competing Interests: Declaration of competing interest I wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
(Copyright © 2024 Elsevier B.V. All rights reserved.)